Skip to main content
SpringerLink
Log in
Book cover

DNA Tumor Viruses pp 259–284Cite as

Epstein–Barr Virus Transforming Proteins: Biologic Properties and Contribution to Oncogenesis

  • Chapter
  • First Online:

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Adams, A. and Lindahl, T. (1975) Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci USA. 72, 1477–1481.

    PubMed  CAS  Google Scholar 

  • Altmann, M., Pich, D., Ruiss, R., Wang, J., Sugden, B. and Hammerschmidt, W. (2006) Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc Natl Acad Sci USA. 103, 14188–14193.

    PubMed  CAS  Google Scholar 

  • Ardila-Osorio, H., Clausse, B., Mishal, Z., Wiels, J., Tursz, T. and Busson, P. (1999) Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells. Int J Cancer. 81, 645–649.

    PubMed  CAS  Google Scholar 

  • Arrand, J. R. and Rymo, L. (1982) Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J Virol. 41, 376–389.

    PubMed  CAS  Google Scholar 

  • Bartel, D. (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116, 281–297.

    PubMed  CAS  Google Scholar 

  • Basseres, D. S. and Baldwin, A. S. (2006) Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene. 25, 6817–6830.

    PubMed  CAS  Google Scholar 

  • Bollard, C. M., Gottschalk, S., Huls, M. H., Molldrem, J., Przepiorka, D., Rooney, C. M. and Heslop, H. E. (2006) In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation. Leuk Lymphoma. 47, 837–842.

    PubMed  Google Scholar 

  • Brazil, D. P., Park, J. and Hemmings, B. A. (2002) PKB binding proteins. Getting in on the Akt. Cell. 111, 293–303.

    CAS  Google Scholar 

  • Busson, P., McCoy, R., Sadler, R., Gilligan, K., Tursz, T. and Raab-Traub, N. (1992) Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol. 66, 3257–3262.

    PubMed  CAS  Google Scholar 

  • Cai, X., Schafer, A., Lu, S., Bilello, J. P., Desrosiers, R. C., Edwards, R., Raab-Traub, N. and Cullen, B. R. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2, e23.

    PubMed  Google Scholar 

  • Caldwell, R. G., Brown, R. C. and Longnecker, R. (2000) Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. J Virol. 74, 1101–1113.

    PubMed  CAS  Google Scholar 

  • Caldwell, R. G., Wilson, J. B., Anderson, S. J. and Longnecker, R. (1998) Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity. 9, 405–411.

    PubMed  CAS  Google Scholar 

  • Chen H, Hutt-Fletcher L., Cao L, Hayward SD. (2003) A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J Virol. 77, 4139–4148.

    PubMed  CAS  Google Scholar 

  • Chen, H., Lee, J. M., Zong, Y., Borowitz, M., Ng, M. H., Ambinder, R. F. and Hayward, S. D. (2001) Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. J Virol. 75, 2929–2937.

    PubMed  CAS  Google Scholar 

  • Cohen, J. I. and Lekstrom, K. (1999) Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J Virol. 73, 7627–7632.

    PubMed  CAS  Google Scholar 

  • Curran, J. A., Laverty, F. S., Campbell, D., Macdiarmid, J. and Wilson, J. B. (2001) Epstein-Barr virus encoded latent membrane protein-1 induces epithelial cell proliferation and sensitizes transgenic mice to chemical carcinogenesis. Cancer Res. 61, 6730–6738.

    PubMed  CAS  Google Scholar 

  • Dawson, C. W., Rickinson, A. B. and Young, L. S. (1990) Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature. 344, 777–780.

    PubMed  CAS  Google Scholar 

  • Dawson, C. W., Tramountanis, G., Eliopoulos, A. G. and Young, L. S. (2003) Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Activates the Phosphatidylinositol 3-Kinase/Akt Pathway to Promote Cell Survival and Induce Actin Filament Remodeling. J Biol Chem. 278, 3694–3704.

    PubMed  CAS  Google Scholar 

  • Dawson, C. W. and Young, L. S. (2001) In vitro assays to study epithelial cell growth. Methods Mol Biol. 174, 165–172.

    PubMed  CAS  Google Scholar 

  • Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn, F. G., Scheidereit, C. and Leutz, A. (1999) The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene. 18, 3316–3323.

    PubMed  CAS  Google Scholar 

  • Devergne, O., Hatzivassiliou, E., Izumi, K. M., Kaye, K. M., Kleijnen, M. F., Kieff, E. and Mosialos, G. (1996) Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol Cell Biol. 16, 7098–7108.

    PubMed  CAS  Google Scholar 

  • Edwards, R., Sitki-Green, D, Moore, DT, and Raab-Traub, N. (2004) Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma. J. Virology. 78, 868–881.

    PubMed  CAS  Google Scholar 

  • Edwards, R. H., Seillier-Moiseiwitsch, F. and Raab-Traub, N. (1999) Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology. 261, 79–95.

    PubMed  CAS  Google Scholar 

  • Eliopoulos, A. G., Blake, S. M., Floettmann, J. E., Rowe, M. and Young, L. S. (1999a) Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J Virol. 73, 1023–1035.

    Google Scholar 

  • Eliopoulos, A. G., Caamano, J. H., Flavell, J., Reynolds, G. M., Murray, P. G., Poyet, J. L. and Young, L. S. (2003) Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. Oncogene. 22, 7557–7569.

    PubMed  CAS  Google Scholar 

  • Eliopoulos, A. G., Gallagher, N. J., Blake, S. M., Dawson, C. W. and Young, L. S. (1999b) Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem. 274, 16085–16096.

    Google Scholar 

  • Eliopoulos, A. G., Waites, E. R., Blake, S. M., Davies, C., Murray, P. and Young, L. S. (2003) TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40. J Virol. 77, 1316–1328.

    PubMed  CAS  Google Scholar 

  • Eliopoulos, A. G. and Young, L. S. (1998) Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene. 16, 1731–1742.

    PubMed  CAS  Google Scholar 

  • Everly, D. N., Jr., Kusano, S. and Raab-Traub, N. (2004) Accumulation of cytoplasmic beta-catenin and nuclear glycogen synthase kinase 3beta in Epstein-Barr virus-infected cells. J Virol. 78, 11648–11655.

    PubMed  CAS  Google Scholar 

  • Everly, D. N., Jr., Mainou, B. A. and Raab-Traub, N. (2004) Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol. 78, 13470–13478.

    PubMed  CAS  Google Scholar 

  • Fukuda, M. and Longnecker, R. (2007) Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway. J Virol. 81, 9299–9306.

    PubMed  CAS  Google Scholar 

  • Ghogomu, S. M., van Venrooy, S., Ritthaler, M., Wedlich, D. and Gradl, D. (2006) HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription. J Biol Chem. 281, 1755–1764.

    PubMed  CAS  Google Scholar 

  • Ghosh, S. and Karin, M. (2002) Missing pieces in the NF-kappaB puzzle.Cell. 109 Suppl, S81–S96.

    PubMed  Google Scholar 

  • Gilligan, K., Rajadurai, P., Resnick, L. and Raab-Traub, N. (1990a) Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci USA. 87, 8790–8794.

    Google Scholar 

  • Gilligan, K., Sato, H., Rajadurai, P., Busson, P., Young, L., Rickinson, A., Tursz, T. and Raab-Traub, N. (1990b) Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol. 64, 4948–4956.

    Google Scholar 

  • Gilligan, K. J., Rajadurai, P., Lin, J. C., Busson, P., Abdel-Hamid, M., Prasad, U., Tursz, T. and Raab-Traub, N. (1991) Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol. 65, 6252–6259.

    PubMed  CAS  Google Scholar 

  • Heissmeyer, V., Krappmann, D., Wulczyn, F. G. and Scheidereit, C. (1999) NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes. Embo J. 18, 4766–4778.

    PubMed  CAS  Google Scholar 

  • Herbst, H., Pallesen, G., Weiss, L. M., Delsol, G., Jarrett, R. F., Steinbrecher, E., Stein, H., Hamilton-Dutoit, S. and Brousset, P. (1992) Hodgkin's disease and Epstein-Barr virus. Ann Oncol. 3 Suppl 4, 27–30.

    Google Scholar 

  • Howe, J. G. and Steitz, J. A. (1986) Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA. 83, 9006–9010.

    PubMed  CAS  Google Scholar 

  • Huen, D. S., Henderson, S. A., Croom-Carter, D. and Rowe, M. (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 10, 549–560.

    PubMed  CAS  Google Scholar 

  • Humme, S., Reisbach, G., Feederle, R., Delecluse, H. J., Bousset, K., Hammerschmidt, W. and Schepers, A. (2003) The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci USA. 100, 10989–10994.

    PubMed  CAS  Google Scholar 

  • Ikeda, A., Merchant, M., Lev, L., Longnecker, R. and Ikeda, M. (2004) Latent membrane protein 2A, a viral B cell receptor homologue, induces CD5+ B-1 cell development. J Immunol. 172, 5329–5337.

    PubMed  CAS  Google Scholar 

  • Ikeda, M., Ikeda, A. and Longnecker, R. (2001) PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins. J Virol. 75, 5711–5718.

    PubMed  CAS  Google Scholar 

  • Izumi, K. M. and Kieff, E. D. (1997) The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc Natl Acad Sci USA. 94, 12592–12597.

    PubMed  CAS  Google Scholar 

  • Izumi, K. M., McFarland, E. C., Ting, A. T., Riley, E. A., Seed, B. and Kieff, E. D. (1999) The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation. Mol Cell Biol. 19, 5759–5767.

    PubMed  CAS  Google Scholar 

  • Jang, K. L., Shackelford, J., Seo, S. Y. and Pagano, J. S. (2005) Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Proc Natl Acad Sci USA. 102, 18431–18436.

    PubMed  CAS  Google Scholar 

  • Kang, M. S., Hung, S. C. and Kieff, E. (2001) Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth. Proc Natl Acad Sci USA. 98, 15233–15238.

    PubMed  CAS  Google Scholar 

  • Kang, M. S., Lu, H., Yasui, T., Sharpe, A., Warren, H., Cahir-McFarland, E., Bronson, R., Hung, S. C. and Kieff, E. (2005) Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proc Natl Acad Sci USA. 102, 820–825.

    PubMed  CAS  Google Scholar 

  • Karin, M. (2006) NF-kappaB and cancer: mechanisms and targets. Mol Carcinog. 45, 355–361.

    PubMed  CAS  Google Scholar 

  • Kato, H., Sakai, T., Tamura, K., Minoguchi, S., Shirayoshi, Y., Hamada, Y., Tsujimoto, Y. and Honjo, T. (1996) Functional conservation of mouse Notch receptor family members. FEBS Lett. 395, 221–224.

    PubMed  CAS  Google Scholar 

  • Kaye, K. M., Izumi, K. M. and Kieff, E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA. 90, 9150–9154.

    PubMed  CAS  Google Scholar 

  • Kaye, K. M., Izumi, K. M., Li, H., Johannsen, E., Davidson, D., Longnecker, R. and Kieff, E. (1999) An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation. J Virol. 73, 10525–10530.

    PubMed  CAS  Google Scholar 

  • Knecht, H., Bachmann, E., Brousset, P., Sandvej, K., Nadal, D., Bachmann, F., Odermatt, B. F., Delsol, G. and Pallesen, G. (1993) Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood. 82, 2937–2942.

    PubMed  CAS  Google Scholar 

  • Kulwichit, W., Edwards, R. H., Davenport, E. M., Baskar, J. F., Godfrey, V. and Raab-Traub, N. (1998) Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci USA. 95, 11963–11968.

    PubMed  CAS  Google Scholar 

  • Lennette, E. T., Rymo, L., Yadav, M., Masucci, G., Merk, K., Timar, L. and Klein, G. (1993) Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6. Eur J Cancer. 11, 1584–1589.

    Google Scholar 

  • Lerner, M. R., Andrews, N. C., Miller, G. and Steitz, J. A. (1981) Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA. 78, 805–809.

    PubMed  CAS  Google Scholar 

  • Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G. and Masucci, M. G. (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 375, 685–688.

    PubMed  CAS  Google Scholar 

  • Lo, A. K., Liu, Y., Wang, X. H., Huang, D. P., Yuen, P. W., Wong, Y. C. and Tsao, G. S. (2003) Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1. Lab Invest. 83, 697–709.

    PubMed  CAS  Google Scholar 

  • Longan, L. and Longnecker, R. (2000) Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia. J Gen Virol. 81, 2245–2252.

    PubMed  CAS  Google Scholar 

  • Longnecker, R., Druker, B., Roberts, T. M. and Kieff, E. (1991) An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J Virol. 65, 3681–3692.

    PubMed  CAS  Google Scholar 

  • Longnecker, R. and Kieff, E. (1990) A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J Virol. 64, 2319–2326.

    PubMed  CAS  Google Scholar 

  • Longnecker, R., Miller, C. L., Miao, X. Q., Marchini, A. and Kieff, E. (1992) The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential. J Virol. 66, 6461–6469.

    PubMed  CAS  Google Scholar 

  • Longnecker, R., Miller, C. L., Miao, X. Q., Tomkinson, B. and Kieff, E. (1993a) The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. J Virol. 67, 2006–2013.

    Google Scholar 

  • Longnecker, R., Miller, C. L., Tomkinson, B., Miao, X. Q. and Kieff, E. (1993b) Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. J Virol. 67, 5068–5074.

    Google Scholar 

  • Luftig, M., Prinarakis, E., Yasui, T., Tsichritzis, T., Cahir-McFarland, E., Inoue, J., Nakano, H., Mak, T. W., Yeh, W. C., Li, X., Akira, S., Suzuki, N., Suzuki, S., Mosialos, G. and Kieff, E. (2003) Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6. Proc Natl Acad Sci USA. 100, 15595–15600.

    PubMed  CAS  Google Scholar 

  • Luftig, M., Yasui, T., Soni, V., Kang, M. S., Jacobson, N., Cahir-McFarland, E., Seed, B. and Kieff, E. (2004) Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Proc Natl Acad Sci USA. 101, 141–146.

    PubMed  CAS  Google Scholar 

  • Mainou, B. A., Everly, D. N., Jr. and Raab-Traub, N. (2005) Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene. 24, 6917–6924.

    PubMed  CAS  Google Scholar 

  • Mainou, B. A., Everly, D. N., Jr. and Raab-Traub, N. (2007) Unique Signaling Properties of CTAR1 in LMP1-Mediated Transformation. J Virol. 81, 9680–9692.

    PubMed  CAS  Google Scholar 

  • Mainou, B. A. and Raab-Traub, N. (2006) LMP1 strain variants: biological and molecular properties. J Virol. 80, 6458–6468.

    PubMed  CAS  Google Scholar 

  • Marchini, A., Cohen, J. I., Wang, F. and Kieff, E. (1992) A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant. J Virol. 66, 3214–3219.

    PubMed  CAS  Google Scholar 

  • Marchini, A., Kieff, E. and Longnecker, R. (1993) Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line: a method useful for analysis of genes essential for transformation. J Virol. 67, 606–609.

    PubMed  CAS  Google Scholar 

  • Miller, C. L., Lee, J. H., Kieff, E., Burkhardt, A. L., Bolen, J. B. and Longnecker, R. (1994) Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction. Infect Agents Dis. 3, 128–136.

    PubMed  CAS  Google Scholar 

  • Miller, C. L., Longnecker, R. and Kieff, E. (1993) Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J Virol. 67, 3087–3094.

    PubMed  CAS  Google Scholar 

  • Miller, G., Niederman, J. C. and Andrews, L. L. (1973) Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med. 288, 229–232.

    PubMed  CAS  Google Scholar 

  • Miller, W. E., Cheshire, J. L. and Raab-Traub, N. (1998) Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression. Mol Cell Biol. 18, 2835–2844.

    PubMed  CAS  Google Scholar 

  • Miller, W. E., Edwards, R. H., Walling, D. M. and Raab-Traub, N. (1994) Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol. 75, 2729–2740.

    PubMed  CAS  Google Scholar 

  • Miller, W. E., Mosialos, G., Kieff, E. and Raab-Traub, N. (1997) Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation. J Virol. 71, 586–594.

    PubMed  CAS  Google Scholar 

  • Moody, C.A., R. S. Scott, Su, T, Sixbey, JW (2003) Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence. J Virol. 77, 8555–8561.

    PubMed  CAS  Google Scholar 

  • Morin, P. (1999) β-Catenin signaling and cancer. BioEssays. 21, 1021–1030.

    PubMed  CAS  Google Scholar 

  • Morrison, J. A., Gulley, M. L., Pathmanathan, R. and Raab-Traub, N. (2004) Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res. 64, 5251–5260.

    PubMed  CAS  Google Scholar 

  • Morrison, J. A., Klingelhutz, A. J. and Raab-Traub, N. (2003) Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J Virol. 77, 12276–12284.

    PubMed  CAS  Google Scholar 

  • Morrison, J. A. and Raab-Traub, N. (2005) Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling. J Virol. 79, 2375–2382.

    PubMed  CAS  Google Scholar 

  • Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C. and Kieff, E. (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80, 389–399.

    PubMed  CAS  Google Scholar 

  • Murray, R. J., Kurilla, M. G., Griffin, H. M., Brooks, J. M., Mackett, M., Arrand, J. R., Rowe, M., Burrows, S. R., Moss, D. J., Kieff, E., et al. (1990) Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc Natl Acad Sci USA. 87, 2906–2910.

    PubMed  CAS  Google Scholar 

  • Nanbo, A., Yoshiyama, H. and Takada, K. (2005) Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells. J Virol. 79, 12280–12285.

    PubMed  CAS  Google Scholar 

  • Ooka, T. (2001) Malignant transformation and immortalization assays in animal cells transfected with the BARF1 gene. Methods Mol Biol. 174, 147–154.

    PubMed  CAS  Google Scholar 

  • Osborne, B. and Miele, L. (1999) Notch and the immune system. Immunity. 11, 653–663.

    PubMed  CAS  Google Scholar 

  • Paine, E., Scheinman, R. I., Baldwin, A. S., Jr. and Raab-Traub, N. (1995) Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins. J Virol. 69, 4572–4576.

    PubMed  CAS  Google Scholar 

  • Pathmanathan, R., Prasad, U., Chandrika, G., Sadler, R., Flynn, K. and Raab-Traub, N. (1995) Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol. 146, 1355–1367.

    CAS  Google Scholar 

  • Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K. and Raab-Traub, N. (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma [see comments]. N Engl J Med. 333, 693–698.

    PubMed  CAS  Google Scholar 

  • Pegtel, D. M., Subramanian, A., Sheen, T. S., Tsai, C. H., Golub, T. R. and Thorley-Lawson, D. A. (2005) Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol. 79, 15430–15442.

    PubMed  CAS  Google Scholar 

  • Pfeffer, S., Zavolan, M., Grasser, F. A., Chien, M., Russo, J. J., Ju, J., John, B., Enright, A. J., Marks, D., Sander, C. and Tuschl, T. (2004) Identification of virus-encoded microRNAs. Science. 304, 734–736.

    PubMed  CAS  Google Scholar 

  • Pope, J. H., Scott, W. and Moss, D. J. (1973) Human lymphoid cell transformation by Epstein-Barr virus. Nat New Biol. 246, 140–141.

    PubMed  CAS  Google Scholar 

  • Raab-Traub (1996) Pathogenesis of Epstein-Barr virus and its associated malignancies. Seminars in Virology. 7, 315–323.

    CAS  Google Scholar 

  • Raab-Traub, N., Dambaugh, T. and Kieff, E. (1980) DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell. 22, 257–267.

    PubMed  CAS  Google Scholar 

  • Raab-Traub, N., Hood, R., Yang, C. S., Henry, B. d. and Pagano, J. S. (1983) Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol. 48, 580–590.

    PubMed  CAS  Google Scholar 

  • Rickinson, A. and Kieff, E. (2001) In: Knipe/Di editor Fields Vivology Fourth edition Philadelphia, PA. Lippencott, Williams, and Wilkins Publisher.

    Google Scholar 

  • Roberts, M. L. and Cooper, N. R. (1998) Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology. 240, 93–99.

    PubMed  CAS  Google Scholar 

  • Rothwarf, D. M. and Karin, M. (1999) The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE. 1999, RE1.

    Google Scholar 

  • Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H. and Rickinson, A. B. (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. Embo J. 6, 2743–2751.

    PubMed  CAS  Google Scholar 

  • Sadler, R. H. and Raab-Traub, N. (1995) The Epstein-Barr virus 3. 5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat. J Virol. 69, 4577–4581.

    PubMed  CAS  Google Scholar 

  • Sadler, R. H. and Raab-Traub, N. (1995) Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol. 69, 1132–1141.

    PubMed  CAS  Google Scholar 

  • Samanta, M., Iwakiri, D., Kanda, T., Imaizumi, T. and Takada, K. (2006) EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. Embo J. 25, 4207–4214.

    PubMed  CAS  Google Scholar 

  • Sample, J., Brooks, L., Sample, C., Young, L., Rowe, M., Gregory, C., Rickinson, A. and Kieff, E. (1991) Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci USA. 88, 6343–6347.

    PubMed  CAS  Google Scholar 

  • Sample, J., Liebowitz, D. and Kieff, E. (1989) Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J Virol. 63, 933–937.

    PubMed  CAS  Google Scholar 

  • Saridakis, V., Sheng, Y., Sarkari, F., Holowaty, M. N., Shire, K., Nguyen, T., Zhang, R. G., Liao, J., Lee, W., Edwards, A. M., Arrowsmith, C. H. and Frappier, L. (2005) Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol Cell. 18, 25–36.

    PubMed  CAS  Google Scholar 

  • Scholle, F., Bendt, K. M. and Raab-Traub, N. (2000) Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol. 74, 10681–10689.

    PubMed  CAS  Google Scholar 

  • Scholle, F., Longnecker, R. and Raab-Traub, N. (1999) Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase. J Virol. 73, 4767–4775.

    PubMed  CAS  Google Scholar 

  • Schultheiss, U., Puschner, S., Kremmer, E., Mak, T. W., Engelmann, H., Hammerschmidt, W. and Kieser, A. (2001) TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. Embo J. 20, 5678–5691.

    PubMed  CAS  Google Scholar 

  • Segditsas, S. and Tomlinson, I. (2006) Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene. 25, 7531–7537.

    PubMed  CAS  Google Scholar 

  • Seto, E., Yang, L., Middeldorp, J., Sheen, T. S., Chen, J. Y., Fukayama, M., Eizuru, Y., Ooka, T. and Takada, K. (2005) Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol. 76, 82–88.

    PubMed  CAS  Google Scholar 

  • Shackelford, J., Maier, C. and Pagano, J. S. (2003) Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes. Proc Natl Acad Sci USA. 100, 15572–15576.

    PubMed  CAS  Google Scholar 

  • Shair, K. H. Y., Bendt, K. M., Edwards, R. H., Bedford, E. C., Nielsen, J. N. and Raab-Traub, N. (2007) Akt and NFκB Pathways are Required for Epstein Barr Virus Latent Membrane Protein-1 Malignant Transformation. PLOS Pathogen. 3, e166.

    Google Scholar 

  • Sharp, T. V., Schwemmle, M., Jeffrey, I., Laing, K., Mellor, H., Proud, C. G., Hilse, K. and Clemens, M. J. (1993) Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res. 21, 4483–4490.

    PubMed  CAS  Google Scholar 

  • Sheng, W., Decaussin, G., Ligout, A., Takada, K. and Ooka, T. (2003) Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J Virol. 77, 3859–3865.

    PubMed  Google Scholar 

  • Smith, P. (2001) Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer. Semin Cancer Biol. 11, 469–476.

    PubMed  CAS  Google Scholar 

  • Soni, V., Cahir-McFarland, E. and Kieff, E. (2007) LMP1 TRAFficking activates growth and survival pathways. Adv Exp Med Biol. 597, 173–187.

    PubMed  Google Scholar 

  • Soni, V., Yasui, T., Cahir-McFarland, E. and Kieff, E. (2006) LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaB. J Virol. 80, 10787–10793.

    PubMed  CAS  Google Scholar 

  • Strockbine, L. D., Cohen, J. I., Farrah, T., Lyman, S. D., Wagener, F., DuBose, R. F., Armitage, R. J. and Spriggs, M. K. (1998) The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol. 72, 4015–4021.

    PubMed  CAS  Google Scholar 

  • Tang, W., Pavlish, O. A., Spiegelman, V. S., Parkhitko, A. A. and Fuchs, S. Y. (2003) Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation. J Biol Chem. 278, 48942–48949.

    PubMed  CAS  Google Scholar 

  • Thornberg, N. J. and Raab-Traub, N. (2007) Induction of EGFR expression by EBV LMP1 CTAR1 is mediated by NF-κB p50 Homodimer/ BCL-3 Complexes. J Virol. 81, 12954–12966.

    Google Scholar 

  • Thornburg, N. J., Kulwichit, W., Edwards, R. H., Shair, K. H., Bendt, K. M. and Raab-Traub, N. (2006) LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene. 25, 288–297.

    PubMed  CAS  Google Scholar 

  • Thornburg, N. J., Kusano, S. and Raab-Traub, N. (2004) Identification of Epstein-Barr virus RK-BARF0-interacting proteins and characterization of expression pattern. J Virol. 78, 12848–12856.

    PubMed  CAS  Google Scholar 

  • Thornburg, N. J., Pathmanathan, R. and Raab-Traub, N. (2003) Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res. 63, 8293–8301.

    PubMed  CAS  Google Scholar 

  • Toczyski, D. P., Matera, A. G., Ward, D. C. and Steitz, J. A. (1994) The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proc Natl Acad Sci USA. 91, 3463–3467.

    PubMed  CAS  Google Scholar 

  • Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N. and Kikutani, H. (1999) Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science. 286, 300–303.

    PubMed  CAS  Google Scholar 

  • Wan, J., Zhang, W., Wu, L., Bai, T., Zhang, M., Lo, K. W., Chui, Y. L., Cui, Y., Tao, Q., Yamamoto, M., Akira, S. and Wu, Z. (2006) BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway. Mol Cell Biol. 26, 448–456.

    PubMed  CAS  Google Scholar 

  • Wang, F., Gregory, C., Sample, C., Rowe, M., Liebowitz, D., Murray, R., Rickinson, A. and Kieff, E. (1990) Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol. 64, 2309–2318.

    PubMed  CAS  Google Scholar 

  • Wang, F., Tsang, S. F., Kurilla, M. G., Cohen, J. I. and Kieff, E. (1990) Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol. 64, 3407–3416.

    PubMed  CAS  Google Scholar 

  • Wilson, J. B., Bell, J. L. and Levine, A. J. (1996) Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. Embo J. 15, 3117–3126.

    PubMed  CAS  Google Scholar 

  • Wilson, J. B., Weinberg, W., Johnson, R., Yuspa, S. and Levine, A. J. (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell. 61, 1315–1327.

    PubMed  CAS  Google Scholar 

  • Wood, V. H., O'Neil, J. D., Wei, W., Stewart, S. E., Dawson, C. W. and Young, L. S. (2007) Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene. 26, 4135–4147.

    PubMed  CAS  Google Scholar 

  • Wu, L., Nakano, H. and Wu, Z. (2006) The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1. J Biol Chem. 281, 2162–2169.

    PubMed  CAS  Google Scholar 

  • Xie P, H. B., Bishop GA (2004) Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes. J. Exp Med. 199, 661–671.

    PubMed  CAS  Google Scholar 

  • Xing, L. and Kieff, E. (2007) Epstein-Barr Virus BHRF1 Micro- and Stable RNAs during Latency III and after Induction of Replication. J Virol. 81, 9967–9975.

    PubMed  CAS  Google Scholar 

  • Yajima, M., Kanda, T. and Takada, K. (2005) Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J Virol. 79, 4298–4307.

    PubMed  CAS  Google Scholar 

  • Yates, J., Warren, N., Reisman, D. and Sugden, B. (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA. 81, 3806–3810.

    PubMed  CAS  Google Scholar 

  • Young, L., Alfieri, C., Hennessy, K., Evans, H., O'Hara, C., Anderson, K. C., Ritz, J., Shapiro, R. S., Rickinson, A., Kieff, E., et al. (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med. 321, 1080–1085.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Professor, Department of Microbiology & Immunology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina

    Nancy Raab-Traub

Authors
  1. Nancy Raab-Traub
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nancy Raab-Traub .

Editor information

Editors and Affiliations

  1. University of North Carolina Chapel Hill, NC, USA

    Blossom Damania

  2. University of Pittsburgh Pittsburgh, PA, USA

    James M. Pipas

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Raab-Traub, N. (2009). Epstein–Barr Virus Transforming Proteins: Biologic Properties and Contribution to Oncogenesis. In: Damania, B., Pipas, J.M. (eds) DNA Tumor Viruses. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68945-6_12

Download citation

Publish with us

Policies and ethics

Search

Navigation